期刊文献+

WHO药品检验实验室预认证推动我国药品检验检测机构的国际化 被引量:5

WHO Prequalification Program on Drug Quality Control Laboratories Promotes the Internationalization of Drug Quality Control Laboratories in China
下载PDF
导出
摘要 目的:帮助我国药品检验机构了解并申请世界卫生组织(WHO)药品检验实验室认证项目。方法:参考WHO发布的信息和文献报道,结合实验室现场辅导和检查的体会,从促进检验检测国际化的角度进行分析。结果:介绍了WHO药品检验实验室预认证的目的、适用的检验项目、评估标准、运行程序;回顾了该项目在全球和中国的执行情况;结合实例,深入理解对预认证检查的认识。结论:通过执行符合国际标准的实验室质量管理体系,该项目使我国药品检验机构具备为国际机构和组织提供检测服务的能力和水平。 Objective: The paper aims to facilitate the understanding and even the application of drug quality control laboratories in China on WHO Prequalification Program on drug quality control laboratories.Methods:From the viewpoint of internationalization of drug quality control laboratories,the paper is organized by referring to public information on WHO homepage and relevant academic materials,and by considering the observations during sites inspection and technical support on sites.Results:This paper provides basic information of WHO Prequalification Program on drug quality control laboratories in terms of rational for setting up this program,eligible testing items,assessment standards,procedure.It reviews the operation of this program abroad and in China.With examples,this paper discusses common issues arisen from site inspections.Conclusion:With quality management system in line with international standards,the WHO Prequalification Program makes drug quality laboratories in China be qualified to provide service for international community and organizations.
出处 《中国医药导刊》 2014年第10期1354-1356,共3页 Chinese Journal of Medicinal Guide
基金 中国食品药品检定研究院与世界卫生合作国际人才能力建设项目(2009-2013)
关键词 WHO 药品检验实验室 认证 国际化 WHO Drug quality control laboratory Prequalification Internationalization
  • 相关文献

参考文献16

  • 1中华人民共和国国务院.国家药品安全“十二五”规划(国发[2012]5号).htto://wwwgov.cn/zwgk/2012-02/13/content2065197.htm.
  • 2The important world of drug prequalification.Lancet,2004;364:1830.
  • 3Huang BB,Barber LS,Smid M,et al.Technical gaps faced by Chinese generic medicine manufacturers to achieve the standards of WHO medicines Prequalification.Journal of Generic Medicines,2013; 10:14-21.
  • 4't Hoen EF,Hogerzeil HV, Quick JD,et al.A quite revoluation in global public health:the World Health Organization's Prequalification of Medicines Programme.Journal of Public Health Policy,2014;35(2):137-161.
  • 5SawyerJ著,于盟译世:卫组织预认证:探路国际药品市场的利器.中国医药经贸,2013;11:39-41.
  • 6胡冰.药品预认证程序创立的必然性与重要性[J].亚太传统医药,2007,3(8):91-92. 被引量:4
  • 7王家威,马双成.世界卫生组织药品预认证项目的概述及发展方向[J].中国药事,2009,23(4):390-392. 被引量:12
  • 8井春梅,肖爱丽,张力.WHO药品资格预审规划对我国制药企业国际化的启示[J].中国药事,2011,25(4):402-404. 被引量:5
  • 9世界卫生组织药品预认证项目.世界卫生组织药品检验实验室预认证项目.http://appswho.int/prequal/,2004-01-02/2014-07-02.
  • 10The Expert Review Panel. WHO Prequalification of Medicines Programme. WHO Drug Information,2012;26(2):99-108.

二级参考文献34

  • 1尹卫东.Healive^(TM)甲型肝炎灭活疫苗的生产与应用[J].中国计划免疫,2004,10(3):174-177. 被引量:12
  • 2张皓冰.抗疟药物的现状及研究进展[J].新医学,2005,36(5):297-299. 被引量:9
  • 3陈化新,叶克龙,张家驹,罗兆庄,胡美娇,张遵宝,赵铁镪,夏建华,姜克俭,朱凤才,龙清忠,宋干,刘文雪,朱智勇,王华,童政,吴扬生,俞永新,周燕平,李伟,张平均,王福兴.中国肾综合征出血热疫苗免疫效果评价和免疫策略研究[J].中国媒介生物学及控制杂志,1996,7(4):241-247. 被引量:54
  • 4谢忠平,陈瀚博,沈冬,陈巍,杨丽仙,丁雪凤,王庆玲.口服脊髓灰质炎减毒活疫苗猴体神经毒力试验病理结果分析[J].中国生物制品学杂志,2007,20(3):206-208. 被引量:6
  • 5世界卫生组织.药品预认证项目[EB/OL].[2009-01-20]http://healthtech.who.int/pq/About/Contact.
  • 6World Health Organization and UNICEF. World Malaria Report [M] . Geneva, switzerland, 2005, 39-39.
  • 7World Health Organization. World Health Organization Expert Committee on Specifications for Pharmaceutical Prepara tions, Fortieth Report [M] .Geneva, switzerland, 2006 12-13.
  • 8World Health Organization. How to Develop and Implement a National Drug Policy (Second Edition) [M] . Geneva, switzerland, 2001, 27-27.
  • 9World Health Organization and UNICEF. World Malaria Report [M] . Geneva, switzerland, 2005, 71-71.
  • 10World Health Organization. World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations, Fortieth Report [M] .Geneva, switzerland, 2006 347-347.

共引文献16

同被引文献48

  • 1赵丽艳,孙佰珍,隋红艳.真空采血常见问题的原因及应对措施[J].黑龙江医学,2005,29(2):153-154. 被引量:3
  • 2叶江,谈谭.试论国际制度的合法性及其缺陷——以国际安全制度与人权制度为例[J].世界经济与政治,2005(12):42-49. 被引量:17
  • 3胡冰.药品预认证程序创立的必然性与重要性[J].亚太传统医药,2007,3(8):91-92. 被引量:4
  • 4David W "Childs. The World Health Organization's Prequalificatian Program and Its Potential Effect on Data Exclu- sivity Laws [J]. Food And Drug Law Journal, 2005(60): 87,96.
  • 5Ellen F. M. 't Hoen,Hans V.Hogerzeil, Jonathan D. Quick , and Hiiti B. Sillo. A Quiet Revolution in Global Public Health: The World Health Organization's Prequalification of Medicines Programme [J].Journal of Public Health Policy, 2014,35(2):141,141,152,152.
  • 6WHO Prequalification. Building Quality-assured Manu- facturing Capacity in Nigeria[J]. W H O Drug Information,2014(4) 425-430.
  • 7JacquelineSawyer.世卫组织预认证:探路国际药品市场的利器[J].中国医药经贸,2013(11):41.
  • 8WHO expert committee on specifications for phar- maceutical preparations.Annex 10 for prequa!ification of phar- maceutical products[R].WHO Technical Report Series, No. 961, 2011 : 373-375.
  • 9卫生部.药品生产质量管理规范[S].中华人民共和国卫生部令第79号.2011.
  • 10World Health Organization(WHO). WHO Guideline on GoodPractices for Pharmaceutical Quality Control Laboratories [S]. WHO Technical Report Series, No. 957,2010.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部